A detailed history of Ballast Asset Management, LP transactions in Iradimed Corp stock. As of the latest transaction made, Ballast Asset Management, LP holds 41,708 shares of IRMD stock, worth $2.22 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
41,708
Previous 42,300 1.4%
Holding current value
$2.22 Million
Previous $1.86 Billion 12.85%
% of portfolio
1.07%
Previous 1.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$43.23 - $50.29 $25,592 - $29,771
-592 Reduced 1.4%
41,708 $2.1 Billion
Q2 2024

Aug 14, 2024

BUY
$40.36 - $44.7 $102,837 - $113,895
2,548 Added 6.41%
42,300 $1.86 Billion
Q1 2024

May 15, 2024

BUY
$41.17 - $47.29 $145,247 - $166,839
3,528 Added 9.74%
39,752 $1.75 Billion
Q4 2023

Feb 14, 2024

BUY
$37.31 - $47.47 $415,484 - $528,625
11,136 Added 44.39%
36,224 $1.72 Billion
Q3 2023

Nov 13, 2023

BUY
$43.28 - $50.3 $1.09 Million - $1.26 Million
25,088 New
25,088 $1.11 Billion

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $669M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Ballast Asset Management, LP Portfolio

Follow Ballast Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballast Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Ballast Asset Management, LP with notifications on news.